NCT06250036
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06250036
Title Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer (ZODIAC)
Acronym ZODIAC
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Royal Marsden NHS Foundation Trust
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Addenbrooke's Hospital Cambridge Cambridgeshire CB2 0QQ United Kingdom Details
Royal Devon University Healthcare Foundation Trust Exeter Devon EX2 5DW United Kingdom Details
Kent & Canterbury Hospital Canterbury Kent CT1 3NG United Kingdom Details
St James's University hospital Leeds Yorkshire LS9 7TF United Kingdom Details
Ninewells hospital and Medical School Dundee DD1 9SY United Kingdom Details
St Bartholomew's Hospital London EC1A 7BE United Kingdom Details
University College London Hospital NHS Foundation Trust London N15 6UL United Kingdom Details
The Royal Free NHS Foundation Trust London NW32QG United Kingdom Details
Guy's and St Thomas' NHS Foundation Trust London SE1 9RT United Kingdom Details
The Royal Marsden NHSFT London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field